Ken Griffin Insulet Corp Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Insulet Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 55,300 shares of PODD stock, worth $18.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,300
Previous 73,800
25.07%
Holding current value
$18.8 Million
Previous $19.4 Million
10.35%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding PODD
# of Institutions
888Shares Held
62.8MCall Options Held
300KPut Options Held
625K-
Vanguard Group Inc Valley Forge, PA8.71MShares$2.96 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$2.06 Billion0.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.74MShares$1.61 Billion0.31% of portfolio
-
State Street Corp Boston, MA3.06MShares$1.04 Billion0.04% of portfolio
-
Baillie Gifford & CO2.14MShares$727 Million0.53% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $23.6B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...